170 results on '"Rugeri, L."'
Search Results
2. Personalized thromboprophylaxis using a risk score for the management of pregnancies with high risk of thrombosis: a prospective clinical study
3. Efficacy, safety and consumption of plasma-derived von Willebrand factor (VWF)/Factor VIII (FVIII) concentrate with 2.4:1 VWF:FVIII ratio for the treatment of von Willebrand Disease: a systematic review
4. Comparison of an automated chemiluminescent assay to a manual ELISA assay for determination of von Willebrand Factor collagen binding activity on VWD plasma patients previously diagnosed through molecular analysis of VWF
5. Combined life-threatening thromboses and hemorrhages in a patient with afibrinogenemia and antithrombin deficiency
6. Efficacy and safety of high ration HVWF/FVIII concentrate (VONCENTO (R)) for the treatment of bleeding epidodes in patients with WITH VON WILLEBRAND disease :s: the OPALE French experience
7. Diagnostic et prise en charge de la coagulopathie post-traumatique
8. Genotyping Might Help Therapeutic Decision Making in Patients with Von Willebrand Disease Type 2 B (VWD2B): OR07
9. Prospective evaluation of automatized PF4/heparin immunoassays HemosIL HIT-ab (PF4-H) for the diagnosis of heparin-induced thrombocytopenia
10. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography
11. Comparison of hyperfibrinolysis in trauma and non-trauma patients
12. Biologic response to desmopressin is there predictable in patients from the same family?: PB 1.43–5
13. Von Willebrand factor activity determination using new assay principle ristocetin-free for reliable von Willebrand disease diagnosis: PA 1.09–2
14. Thrombin generation in patients with factor XI deficiency and clinical bleeding risk
15. Contribution of genetical analysis for diagnosis of von Willebrandʼs disease type 2B
16. A new electrophoretic variant of fibrinogen associated with venous thromboembolism, fibrinogen Bordeaux Aα Arg439→Cys
17. Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients
18. A new ELISA assay for diagnosis of acquired von Willebrand Syndrome
19. MATERNAL AND NEONATAL AUTOIMMUNE THROMBOCYTOPENIA
20. After the SIPPET study: Position paper of the CoMETH, the French society of haemophilia
21. Comparison of an automated chemiluminescent assay to a manual ELISA assay for determination of von Willebrand Factor collagen binding activity on VWD plasma patients previously diagnosed through molecular analysis ofVWF
22. T-15-02: Efficacy, safety and consumption of plasma-derived von Willebrand factor (VWF)/Factor VIII (FVIII) concentrate with 2.4:1 VWF:FVIII ratio for the treatment of von Willebrand Disease: a systematic review.
23. A single‐centre study of haemostatic outcomes of joint replacement in von Willebrand disease and control patients and an analysis of the literature
24. Comparison of an automated chemiluminescent assay to a manual ELISA assay for determination of von Willebrand Factor collagen binding activity on VWD plasma patients previously diagnosed through molecular analysis of <italic>VWF</italic>.
25. Évaluation prospective sur 10ans du score de Lyon dans la prévention de la maladie thromboembolique chez la femme enceinte. Résultats sur 445 patientes à risque
26. Prise en charge anesthésique d’une hémorragie du post-partum sévère ou résistant au traitement médical
27. Intérêt des nouveaux marqueurs de la dégradation de la fibrine pour le calcul du score ISTH
28. Étude du profil thromboélastographique en transplantation rein-pancréas
29. Prospective evaluation of automatized PF4/heparin immunoassays HemosIL HIT-ab (PF4-H) for the diagnosis of heparin-induced thrombocytopenia
30. Progressive endothelial damage revealed by multilevel von Willebrand factor plasma concentrations in atrial fibrillation patients
31. OC-14 Pregnancy related thrombosis risk in patients with protein C deficiency
32. Place du fibrinogène dans le choc hémorragique chez un polytraumatisé : à propos d’un cas
33. Le déficit acquis en facteur V : une pathologie hémorragique rare à manifestations cliniques variables
34. P3 A score based prevention strategy of venous thromboembolism in pregnant women
35. Déficit combiné en facteurs V et VIII de la coagulation : ou quand la génétique nous explique les déficits combinés de facteurs de la coagulation
36. Thrombin-generating capacity in patients with von Willebrand's disease
37. Thromboélastométrie rotative : réhabilitation de l'ancienne thromboélastographie
38. Management of pregnant women with increased risk of venous thrombosis
39. Multiple arterial thromboses in a patient with primary antiphospholipid syndrome receiving a bromocriptine therapy
40. Clinical Usefulness of Combined use of Platelet Aggregation Test and Anti PF4-H. Antibodies Elisa test for the Diagnosis of Heparin Induced Thrombocytopenia
41. Impact d'une démarche qualité en sécurité transfusionnelle sur la prescription, l'optimisation des circuits, la traçabilité
42. Utility of a point-of-care device for rapid determination of prothrombin time in trauma patients: a preliminary study.
43. Early coagulopathy in trauma patients: An on-scene and hospital admission study.
44. Basic fibroblast growth factor increases tissue factor expression in circulating monocytes and in vascular wall.
45. Liste des auteurs
46. Factor VII, Tissue Factor Pathway Inhibitor, and Monocyte Tissue Factor in Diabetes Mellitus: Influence of Type of Diabetes, Obesity Index, and Age
47. Monocyte Tissue Factor Response Is Decreased in Patients with Hyperlipidemia - II. Effect on induction of endothelial cell procoagulant activity
48. MATERNAL AND NEONATAL AUTOIMMUNE THROMBOCYTOPENIA.
49. Évaluation prospective sur 10 ans du score de Lyon dans la prévention de la maladie thromboembolique chez la femme enceinte. Résultats sur 445 patientes à risque.
50. A Systematic Review of Efficacy and Safety of Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Voncento) in von Willebrand Disease.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.